Four human FANCG polymorphic variants show normal biological function in hamster CHO cells

John M. Hinz, Peter B. Nham, N. Alice Yamada, Robert S. Tebbs, Edmund P. Salazar, Angela K. Hinz, Harvey W. Mohrenweiser, Irene M. Jones, Larry H. Thompson

Research output: Contribution to journalArticle

Abstract

Fanconi anemia (FA) is a rare cancer predisposition disease caused by mutations in at least 12 genes encoding proteins that cooperate to maintain genomic integrity. Variants of FA genes, including FANCG, have been identified in human population screening, but their potential reduction in protein function and role in cancer susceptibility is unclear. To test for possible dysfunction, we constructed plasmids containing four FANCG polymorphisms found in the human population and introduced them in the Fancg-deficient (fancg) KO40 line derived from AA8 hamster CHO cells. Expression of wild-type human FANCG provided fancg cells with complete phenotypic correction as assessed by resistance to the DNA crosslinking agent mitomycin C (MMC), thus providing a sensitive test for detecting the degree of complementation activity for the FANCG variants. We found that all four variants conferred levels of mitomycin C resistance as well as restoration of monoubiquitination of Fancd2, a key indicator of a functional FA protein pathway, similar to those observed in wild-type transfectants. Under the same conditions, the L71P amino acid substitution mutant, identified in an FA patient, gave no complementation. Using this novel system for determining FANCG functionality, we detect no decrement in function of the human FANCG polymorphic variants examined.

Original languageEnglish (US)
Pages (from-to)34-42
Number of pages9
JournalMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Volume602
Issue number1-2
DOIs
StatePublished - Dec 1 2006
Externally publishedYes

Fingerprint

CHO Cells
Fanconi Anemia
Cricetinae
Mitomycin
Fanconi Anemia Complementation Group Proteins
Amino Acid Substitution
Population
Neoplasms
Proteins
Plasmids
Mutation
DNA
Genes

Keywords

  • CHO cells
  • FANCD2 monoubiquitination
  • Fanconi anemia
  • Mitomycin C sensitivity
  • Polymorphisms

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Molecular Biology

Cite this

Four human FANCG polymorphic variants show normal biological function in hamster CHO cells. / Hinz, John M.; Nham, Peter B.; Yamada, N. Alice; Tebbs, Robert S.; Salazar, Edmund P.; Hinz, Angela K.; Mohrenweiser, Harvey W.; Jones, Irene M.; Thompson, Larry H.

In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 602, No. 1-2, 01.12.2006, p. 34-42.

Research output: Contribution to journalArticle

Hinz, JM, Nham, PB, Yamada, NA, Tebbs, RS, Salazar, EP, Hinz, AK, Mohrenweiser, HW, Jones, IM & Thompson, LH 2006, 'Four human FANCG polymorphic variants show normal biological function in hamster CHO cells', Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, vol. 602, no. 1-2, pp. 34-42. https://doi.org/10.1016/j.mrfmmm.2006.07.008
Hinz, John M. ; Nham, Peter B. ; Yamada, N. Alice ; Tebbs, Robert S. ; Salazar, Edmund P. ; Hinz, Angela K. ; Mohrenweiser, Harvey W. ; Jones, Irene M. ; Thompson, Larry H. / Four human FANCG polymorphic variants show normal biological function in hamster CHO cells. In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 2006 ; Vol. 602, No. 1-2. pp. 34-42.
@article{b1922fceeb6a4a1f8e57a2fe2a11c87d,
title = "Four human FANCG polymorphic variants show normal biological function in hamster CHO cells",
abstract = "Fanconi anemia (FA) is a rare cancer predisposition disease caused by mutations in at least 12 genes encoding proteins that cooperate to maintain genomic integrity. Variants of FA genes, including FANCG, have been identified in human population screening, but their potential reduction in protein function and role in cancer susceptibility is unclear. To test for possible dysfunction, we constructed plasmids containing four FANCG polymorphisms found in the human population and introduced them in the Fancg-deficient (fancg) KO40 line derived from AA8 hamster CHO cells. Expression of wild-type human FANCG provided fancg cells with complete phenotypic correction as assessed by resistance to the DNA crosslinking agent mitomycin C (MMC), thus providing a sensitive test for detecting the degree of complementation activity for the FANCG variants. We found that all four variants conferred levels of mitomycin C resistance as well as restoration of monoubiquitination of Fancd2, a key indicator of a functional FA protein pathway, similar to those observed in wild-type transfectants. Under the same conditions, the L71P amino acid substitution mutant, identified in an FA patient, gave no complementation. Using this novel system for determining FANCG functionality, we detect no decrement in function of the human FANCG polymorphic variants examined.",
keywords = "CHO cells, FANCD2 monoubiquitination, Fanconi anemia, Mitomycin C sensitivity, Polymorphisms",
author = "Hinz, {John M.} and Nham, {Peter B.} and Yamada, {N. Alice} and Tebbs, {Robert S.} and Salazar, {Edmund P.} and Hinz, {Angela K.} and Mohrenweiser, {Harvey W.} and Jones, {Irene M.} and Thompson, {Larry H.}",
year = "2006",
month = "12",
day = "1",
doi = "10.1016/j.mrfmmm.2006.07.008",
language = "English (US)",
volume = "602",
pages = "34--42",
journal = "Mutation Research",
issn = "0027-5107",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Four human FANCG polymorphic variants show normal biological function in hamster CHO cells

AU - Hinz, John M.

AU - Nham, Peter B.

AU - Yamada, N. Alice

AU - Tebbs, Robert S.

AU - Salazar, Edmund P.

AU - Hinz, Angela K.

AU - Mohrenweiser, Harvey W.

AU - Jones, Irene M.

AU - Thompson, Larry H.

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Fanconi anemia (FA) is a rare cancer predisposition disease caused by mutations in at least 12 genes encoding proteins that cooperate to maintain genomic integrity. Variants of FA genes, including FANCG, have been identified in human population screening, but their potential reduction in protein function and role in cancer susceptibility is unclear. To test for possible dysfunction, we constructed plasmids containing four FANCG polymorphisms found in the human population and introduced them in the Fancg-deficient (fancg) KO40 line derived from AA8 hamster CHO cells. Expression of wild-type human FANCG provided fancg cells with complete phenotypic correction as assessed by resistance to the DNA crosslinking agent mitomycin C (MMC), thus providing a sensitive test for detecting the degree of complementation activity for the FANCG variants. We found that all four variants conferred levels of mitomycin C resistance as well as restoration of monoubiquitination of Fancd2, a key indicator of a functional FA protein pathway, similar to those observed in wild-type transfectants. Under the same conditions, the L71P amino acid substitution mutant, identified in an FA patient, gave no complementation. Using this novel system for determining FANCG functionality, we detect no decrement in function of the human FANCG polymorphic variants examined.

AB - Fanconi anemia (FA) is a rare cancer predisposition disease caused by mutations in at least 12 genes encoding proteins that cooperate to maintain genomic integrity. Variants of FA genes, including FANCG, have been identified in human population screening, but their potential reduction in protein function and role in cancer susceptibility is unclear. To test for possible dysfunction, we constructed plasmids containing four FANCG polymorphisms found in the human population and introduced them in the Fancg-deficient (fancg) KO40 line derived from AA8 hamster CHO cells. Expression of wild-type human FANCG provided fancg cells with complete phenotypic correction as assessed by resistance to the DNA crosslinking agent mitomycin C (MMC), thus providing a sensitive test for detecting the degree of complementation activity for the FANCG variants. We found that all four variants conferred levels of mitomycin C resistance as well as restoration of monoubiquitination of Fancd2, a key indicator of a functional FA protein pathway, similar to those observed in wild-type transfectants. Under the same conditions, the L71P amino acid substitution mutant, identified in an FA patient, gave no complementation. Using this novel system for determining FANCG functionality, we detect no decrement in function of the human FANCG polymorphic variants examined.

KW - CHO cells

KW - FANCD2 monoubiquitination

KW - Fanconi anemia

KW - Mitomycin C sensitivity

KW - Polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=33750611618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750611618&partnerID=8YFLogxK

U2 - 10.1016/j.mrfmmm.2006.07.008

DO - 10.1016/j.mrfmmm.2006.07.008

M3 - Article

C2 - 17010390

AN - SCOPUS:33750611618

VL - 602

SP - 34

EP - 42

JO - Mutation Research

JF - Mutation Research

SN - 0027-5107

IS - 1-2

ER -